Rockville, Maryland — September 29, 2026 The global joint replacement market is estimated at USD 24.24 billion in 2026 and is forecast to reach USD 41.02 billion by 2036, expanding at a 5.4% CAGR during the forecast period. According to Fact.MR, the market is being shaped by increasing surgical volumes, innovation in implant materials, and broader adoption of advanced orthopedic technologies across developed and emerging healthcare systems. The market is expected to create an absolute dollar opportunity of USD 16.78 billion between 2026 and 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

One of the major factors supporting market expansion is the rising prevalence of osteoarthritis among aging populations. Increasing numbers of patients requiring knee and hip procedures are contributing to higher surgical volumes worldwide. At the same time, robotic-assisted surgery is gaining adoption because these systems can support more precise implant positioning and surgical planning. Expanding ambulatory surgical center capacity is also influencing the market by enabling more joint replacement procedures to be performed in outpatient settings while supporting improved patient throughput and cost management.

Knee replacement implants remain the leading product category, accounting for 48% of global product share in 2026. Their substantial share reflects an established clinical presence and continued buyer preference for knee replacement solutions. By application, osteoarthritis treatment represents 55% of the market in 2026, highlighting the central role of degenerative joint disease in driving demand for replacement procedures. The broader product landscape includes hip, shoulder, elbow, and revision joint systems, while technologies span robotic-assisted surgery, minimally invasive surgery, custom implant technology, and advanced bearing surfaces.

Geographically, India is projected to record the fastest growth among the countries assessed in the report, with a CAGR of 7.5% from 2026 to 2036. Fact.MR attributes this expansion to a large untreated osteoarthritis population, wider access to orthopedic surgery through government health schemes, increasing medical tourism, and rising healthcare spending among middle-class consumers. China follows with a 7.2% CAGR, supported by aging demographics, expanding orthopedic surgical capacity, healthcare reforms, and growing adoption of domestic and imported implant systems across hospital networks.

Among the European markets, the United Kingdom is projected to grow at a 4.9% CAGR through 2036. Demand is supported by NHS joint replacement pathways, national joint registry data that informs implant selection, and increasing use of patient-specific surgical planning. Germany is expected to expand at a 4.8% CAGR, with established healthcare infrastructure, national joint registries, clinical outcome tracking, and an aging population contributing to continued demand. Japan records a 5.3% CAGR, supported by its aging population, high healthcare standards, and adoption of robotic-assisted surgery. The United States is projected to grow at 5.0%, reflecting high procedure volumes, robotic surgery adoption, established reimbursement pathways, and increasing activity at ambulatory surgical centers.

The competitive landscape includes several established orthopedic device manufacturers. Key companies profiled by Fact.MR include Stryker Corporation, Zimmer Biomet Holdings Inc., Johnson & Johnson through DePuy Synthes Inc., Smith & Nephew Plc., and DJO Global Inc. (Enovis). Other companies covered include Arthrex Inc., Exactech Inc., MicroPort Orthopedics Inc., Conformis Inc., and Corin Group Ltd. Competition is influenced by implant performance, surgical technology integration, product portfolios, procurement relationships, and the ability to address evolving hospital and outpatient care requirements.

The market is also undergoing a shift toward technology-enabled joint replacement ecosystems. Fact.MR Principal Consultant Shambhu Nath Jha notes that robotic-assisted systems are changing surgical planning and execution, while the movement toward outpatient arthroplasty is affecting cost structures and procurement requirements. The report further highlights opportunities for manufacturers combining implant systems with digital surgery platforms and post-operative monitoring capabilities.

Unlock 360° insights for strategic decision making and investment planning:

With orthopedic procedure volumes increasing and healthcare systems investing in advanced surgical infrastructure, the joint replacement market is expected to remain an important segment of the global medical devices industry through 2036. The complete Fact.MR report provides detailed market sizing, segment forecasts, country-level analysis, competitive assessment, and strategic insights for stakeholders across the orthopedic healthcare value chain.

Explore More Related Studies Published by Fact.MR Research

Smart Blister Lidding Market

Tamper-Evident Syringe Caps Market

Wearable Infusion Adhesives Market

Smoke-Evacuating Trocars Market

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | [email protected]